Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene

Cancer Research

Volumn 59, Issue 22, 1999, Pages 5785-5792

  Chiari, Rita ^a   Foury, Françoise ^a   De Plaen, Eienne ^b   Baurain, Jean François ^a   Thonnard, Joëlle ^a   Coulie, Pierre G ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; HLA C ANTIGEN; MELANOMA ANTIGEN;

ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; MELANOMA CELL; NUCLEOTIDE SEQUENCE; POINT MUTATION; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTIGENS, NEOPLASM; BASE SEQUENCE; DNA, COMPLEMENTARY; GENETIC COMPLEMENTATION TEST; HLA-B ANTIGENS; HUMANS; MELANOMA; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VESICULAR TRANSPORT PROTEINS; YEASTS;

EID: 0033571145     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. De Plaen, E., Arden, K., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
2. Lurquin, C., De Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P., and Boon, T. Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumors of various histological origins. Genomics, 46: 397-408, 1997.
3. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N., and Monaco, A. P. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA, 92: 4987-4991, 1995.
4. Lucas, S., De Smet, C., Arden, K. C., Viars, C. S., Lethé, B., Lurquin, C., and Boon, T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res., 58: 743-752, 1998.
5. Boël, P., Wildmann, C., Sensi, M.-L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T., and van der Bruggen, P. BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2: 167-175, 1995.
6. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med., 182: 689-698, 1995.
7. Lethé, B., Lucas, S., Michaux, L., De Smet, C., Godelaine, D., Serrano, A., De Plaen, E., and Boon, T. LAGE-1 a new gene with tumor specificity. Int. J. Cancer, 76: 903-908, 1998.
8. Chen, Y-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., and Old, L. J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA, 94: 1914-1918, 1997.
9. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., and Boon, T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA, 93: 7149-7153, 1996.
10. Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwijck, R., Humblet, Y., Canon, J-L., Laurent, C., Naeyaert, J-M., Plagne, R., Deraemaeker, R., Knuth, A., Jäger, E., Brasseur, F., Herman, J., Coulie, P. G., and Boon, T. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer, 63: 883-885, 1995.
11. Marchand, M., van Baren, N., Weynants, P., Brichard, V., Dréno, B., Tessier, M-H., Rankin, E., Parmiani, G., Arienti, F., Humblet, Y., Bourlond, A., Vanwijck, R., Liénard, D., Beauduin, M., Dietrich, P-Y., Russo, V., Kerger, J., Masucci, G., Jäger, E., De Greve, J., Atzpodien, J., Brasseur, F., Coulie, P. G., Van der Bruggen, P., and Boon, T. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer, 80: 219-230, 1999.
12. INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma Science (Washington DC), 269: 1281-1284, 1995.
13. Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., and van der Bruggen, P. A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. J. Exp. Med., 186: 785-793, 1997.
14. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J. Exp. Med., 183: 1185-1192, 1996.
15. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., and Polakis, P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science (Washington DC), 275: 1790-1792, 1997.
16. Brichard, V. G., Herman, J., Van Pel, A., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T., and Lethé, B. A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes. Eur. J. Immunol., 26: 224-230, 1996.
17. Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Meyer zum Büschenfelde, K-H., and Boon, T. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol., 24: 759-764, 1994.
18. Schneider, J., Brichard, V., Boon, T., Meyer zum Büschenfelde, K. H., and Wölfel, T. Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1. Int. J. Cancer, 75: 451-458, 1998.
19. Lehmann, F., Marchand, M., Hainaut, P., Pouillart, P., Sastre, X., Ikeda, H., Boon, T., and Coulie, P. G. Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection. Eur. J. Immunol., 25: 340-347, 1995.
20. Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., and Boon, T. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA, 92: 7976-7980, 1995.
21. Van Baren, N., Chambost, H., Ferrant, A., Michaux, L., Ikeda, H., Millard, I., Olive, D., Boon, T., and Coulie, P. G. PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells. Br. J. Haematol., 102: 1376-1379, 1998.
22. Ikeda, H., Lethé, B., Lehmann, F., Van Baren, N., Baurain, J-F., De Smet, C., Chambost, H., Vitale, M., Moretta, A., Boon, T., and Coulie, P. G. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity, 6: 199-208, 1997.
23. Coulie, P. G., Ikeda, H., Baurain, J-F., and Chiari, R. Anti-tumor immunity at work in a melanoma patient. Adv. Cancer Res., 76: 213-242, 1999.
24. Espevik, T., and Nissen-Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods, 95: 99-105, 1986.
25. Atherton, E., Logan, C. J., and Sheppard, R. C. Peptide synthesis. Part 2. Procedures for solid phase synthesis using Nα-fluorenylmethysoxycarbamylamino-acid on polymide supports. Synthesis of substance P and of acyl carrier protein 65-74 decapeptide. J. Chem. Soc. Lond. Perkin Trans., 1: 538-546, 1981.
26. Hansen, M. B., Nielsen, S. E., and Berg, K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods, 119: 203-210, 1989.
27. Rammensee, H-G., Friede, T., and Stevanovic, S. MHC ligands and peptide motifs: first listing. Immunogenetics, 41: 178-228, 1995.
28. Jiang, Y., Scarpa, A., Zhang, L., Stone, S., Feliciano, E., and Ferro-Novick, S. A high copy suppressor screen reveals genetic interactions between BET3 and a new gene. Evidence for a novel complex in ER-to-Golgi transport. Genomics, 149: 833-841, 1998.
29. Rossi, G., Kolstad, K., Stone, S., Palluault, F., and Ferro-Novick, S. BET3 encodes a novel hydrophilic protein that acts in conjunction with yeast SNAREs. Mol. Cell. Biol., 6: 1769-1780, 1995.
30. Sacher, M., Jiang, Y., Barrowman, J., Scarpa, A., Burston, J., Zhang, L., Schieltz, D., Yates, J. R., III, Abeliovich, H., and Ferro-Novick, S. TRAPP, a highly conserved novel complex on the cis-Golgi that mediates vesicle docking and fusion. EMBO J., 17: 2494-2503, 1998.
31. Herman, J., van der Bruggen, P., Luescher, I., Mandruzzato, S., Romero, P., Thonnard, J., Fleischhauer, K., Boon, T., and Coulie, P. G. A peptide encoded by the human gene MAGE-3 and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics, 43: 377-383, 1996.
32. van der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., and Boon, T. A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Eur. J. Immunol., 24: 3038-3043, 1994.
33. van der Bruggen, P., Szikora, J-P., Boël, P., Wildmann, C., Somville, M., Sensi, M., and Boon, T. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur. J. Immunol., 24: 2134-2140, 1994.
34. Traversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., and Boon, T. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J. Exp. Med., 176: 1453-1457, 1992.
35. Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., and Boon, T. Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J. Exp. Med., 179: 921-930, 1994.
36. Wölfel, T., Hauer, M., Klehmann, E., Brichard, V., Ackermann, B., Knuth, A., Boon, T., and Meyer zum Büschenfelde, K-H. Analysis of antigens recognized on human melanoma cells by A2-restricted cytolytic T lymphocytes (CTL). Int. J. Cancer, 55: 237-244, 1993.
37. Brichard, V., Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., and Boon, T. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 178: 489-495, 1993.
38. Coulie, P. G., Brichard, V., Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J-P., Renauld, J-C., and Boon, T. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med., 180: 35-42, 1994.
39. Modrich, P., and Lahue, R. Mismatch repair in replication fidelity, genetic recombination, and cancer biology. Annu. Rev. Biochem., 65: 101-133, 1996.
40. Halaban, R., Bohm, M., Dotto, P., Moellmann, G., Cheng, E., and Zhang, Y. Growth regulatory proteins that repress differentiation markers in melanocytes also down-regulate the transcription factor microphtalmia. J. Invest. Dermatol., 106: 1266-1272, 1996.
41. Yavuzer, U., Keenan, E., Lowings, P., Vachtenheim, J., Currie, G., and Goding, C. R. The Microphtalmia gene product interacts with the retinoblastoma protein in vitro and is a target for deregulation of melanocyte-specific transcription. Oncogene, 10: 123-134, 1995.
42. Thomson, J. A., Murphy, K., Baker, E., Sutherland, G. R., Parsons, P. G., and Sturm, R. A. The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene, 11: 691-700, 1995.
43. Butterfield, L. H., Stoll, T. C., Lau, R., and Economou, J. S. Cloning and analysis of MART-1/Melan-A human melanoma antigen promoter regions. Gene, 191: 129-134, 1997.
44. Fishel, R., Lescoe, M. K., Rao, M. R., Copeland, N. G., Jenkins, N. A., Garber, J., Kane, M., and Kolodner, R. The human mutator gene homolog MSH2 and its association with colon cancer. Cell. 75; 1027-1038, 1993.
45. Kawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., and Rosenberg, S. A. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J. Exp. Med., 180: 347-352, 1994.
46. Culmann, B., Gomard, E., Kiény, M-P., Guy, B., Dreyfus, F., Saimot, A-G., Sereni, D., Sicard, D., and Lévy, J-P. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein. J. Immunol., 146: 1560-1565, 1991.
47. Johnson, R. P., Trocha, A., Buchanan, T. M., and Walker, B. D. Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation. J. Exp. Med., 175: 961-971, 1992.
48. Tussey, L. G., Rowland-Jones, S., Zheng, T. S., Androlewicz, M. J., Cresswell, P., Frelinger, J. A., and McMichael, A. J. Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity, 3: 65-77, 1995.
49. Bogedain, C., Wolf, H., Modrow, S., Stuber, G., and Jilg, W. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol., 69: 4872-4879, 1995.
50. Elliott, T., Smith, M., Driscoll, P., and McMichael. A. Peptide selection by class I molecules of the major histocompatibility complex. Curr. Biol., 3: 854-866, 1993.